Trials / Completed
CompletedNCT05459064
Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 144 (actual)
- Sponsor
- Establishment Labs · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Motiva Flora® TE are intended for temporary subcutaneous or submuscular implantation to develop surgical flaps and additional tissue coverage and are not intended for use beyond six (6) months. All Motiva Flora® TE's require periodic, incremental inflation with sterile saline for injection until the desired tissue amount is developed. After the desired volume, the expander is surgically removed and replaced with a long-term breast implant in the same space as the tissue expander. The study collects retrospective data on the use of the Motiva Flora TE, from patients who had a tissue expander-based-breast reconstruction using the Motiva Flora® TE since market introduction in May 2020.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Motiva Flora TE | This is a retrospective, observational study - collecting data on patients who have gone through the staged procedure with the Motiva Flora Tissue Expander / Long-term breast implant. |
Timeline
- Start date
- 2022-09-01
- Primary completion
- 2024-06-30
- Completion
- 2024-06-30
- First posted
- 2022-07-14
- Last updated
- 2024-08-27
Locations
2 sites across 2 countries: Belgium, Spain
Source: ClinicalTrials.gov record NCT05459064. Inclusion in this directory is not an endorsement.